Trace Genomics

San Francisco, United States Founded: 2015 • Age: 11 yrs
Developer of technologies to diagnose soil health and soil-borne disease prediction

About Trace Genomics

Trace Genomics is a Healthcare company based in San Francisco (United States) founded in 2015. Developer of technologies to diagnose soil health and soil-borne disease prediction. It operates in the Healthcare and Agriculture sectors. Trace Genomics has raised $53.62 million across 6 funding rounds from investors including Illumina, S2G Ventures and Ajax Strategies. The company has 51 employees. Trace Genomics offers products and services including TraceCOMPLETE and Carbon Innovation. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its competitors include Kallyope, AnimalBiome and Biome Makers; 3 of its 3 listed competitors have raised funding.

Company details

Trace Genomics was founded in 2015 in San Francisco, United States, within the agricultural technology sector. Technologies are developed to assess soil health and forecast soil-borne diseases. Soil samples are collected by farmers and agronomists via provided sampling kits and submitted for laboratory testing. Results are delivered through email reports, supporting informed agricultural decisions across operations in the region.

Key Metrics
  • Total Equity Funding
    $53.62M (USD)

    in 6 rounds

  • Latest Funding Round
    $10.5M (USD), Series B

    Feb 2024

  • Investors
    Illumina

    & 9 more

  • Employee Count
    51

Products & Services of Trace Genomics

Trace Genomics offers a comprehensive portfolio of products and services, including TraceCOMPLETE and Carbon Innovation.

TraceCOMPLETE
Diagnostics

Tool for soil intelligence to optimize agricultural decisions and profitability

Carbon Innovation
Sustainability Tools

Solutions for managing carbon in soil to support eco-friendly farming

Funding Insights of Trace Genomics

Trace Genomics has successfully raised a total of $53.62M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $10.5 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $53.62M
  • Total Rounds 6
  • Last Round Series B β€” $10.5M
  • First Round $200,000

    (Jun 2016)

  • Investors Count 10

All 6 funding rounds of Trace Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024$10.5MSeries B–S2G Ventures, Ajax Strategies
–
Jul 2020$17.2MSeries B––
–
Dec 2018$19.72MSeries A–Stage 1 Ventures
Feb 2017$2MSeed–THRIVE
–
Jul 2016$4MSeed–Refactor Capital
Jun 2016$200,000Seed––
Valuation history

10 investors in total: 10 institutional.

Investors in Trace Genomics

Trace Genomics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, S2G Ventures and Ajax Strategies.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Stage agnostic venture capital firm
s2gventures.comChicago, United States
Investment arm of Rabobank, focusing on equity capital provision.
raboinvestments.comUtrecht, Netherlands
Early-stage US companies are invested in by Stage 1 Ventures.
stage1ventures.comWaltham, United States
Venture capital fund focused on ag-tech and food-tech sectors
agfunder.comSan Francisco, United States
Private investment firm focused on multiple sectors
vikingglobal.comGreenwich, United States
Food and agtech startups are accelerated by THRIVE programs.
thriveagrifood.comLos Gatos, United States
VC firm that does early stage investments in the US
fall-line-capital.comSan Mateo, United States
Seed and early-stage investments are made across US and India.
refactor.comBurlingame, United States
Business consulting and strategic marketing services are provided by Ajax Strategies.
2012ajaxstrategies.comChicago, United States
Developer of technologies for analysis of genetic variation and function
1993illumina.comSan Diego, United States
Premium access

Investor details for Trace Genomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Trace Genomics

8 people are tracked at Trace Genomics (1 in leadership, 5 in board & advisors, 2 in team); the tracked headcount is 51.

NameRoleGroup
Adam Burnhams
Chief Marketing OfficerLeadership
Bill Buckner
DirectorBoard & advisors
Robert Fraley
DirectorBoard & advisors
Veery Maxwell
DirectorBoard & advisors
Cristina Rohr
DirectorBoard & advisors
Mike Toelle
DirectorBoard & advisors
Celia Takachi
Laboratory SupervisorTeam
Hee Kyung Lee
Research Associate IITeam
Premium access

Complete people profiles for Trace Genomics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Trace Genomics

3 dated milestones of Trace Genomics across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Trace Genomics is founded.
  2. Funding First funding round of $200K.
  3. Funding Latest funding round, Series B, of $10.5M.

Competitors of Trace Genomics

Trace Genomics has 3 listed competitors in our database, 3 of them funded. They include Kallyope, AnimalBiome and Biome Makers.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kallyope.com2014New York, United States$479M84
The gut-brain axis is explored for therapeutic and nutritional innovations.
animalbiome.com2016San Francisco, United States$25.88M52
Animal microbiome diagnostics services for pet care are offered.
biomemakers.com2015San Francisco, United States$21.2M14
Microbiome technology is developed for vineyard soil analysis.
Premium access

Detailed competitors of Trace Genomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Trace Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Trace Genomics

Premium access

Complete news archive for Trace Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trace Genomics

Trace Genomics was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Trace Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Trace Genomics is a funded company, having raised a total of $53.62M across 6 funding rounds to date. The company's 1st funding round was a Seed of $200K, raised on Jun 2016.

Trace Genomics has 51 employees.

Trace Genomics was founded in 2015 in San Francisco, United States, within the agricultural technology sector. Technologies are developed to assess soil health and forecast soil-borne diseases. Soil samples are collected by farmers and agronomists via provided sampling kits and submitted for laboratory testing. Results are delivered through email reports, supporting informed agricultural decisions across operations in the region.

Trace Genomics's top competitors include Kallyope, Biome Makers and AnimalBiome.

Trace Genomics offers TraceCOMPLETE and Carbon Innovation.

Trace Genomics has 10 investors. Key investors include Illumina, S2G Ventures, Ajax Strategies, Rabo Investments, and Stage 1 Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available